BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1320 related articles for article (PubMed ID: 17070580)

  • 21. Frequency-doubling technology: searching for the optimum diagnostic criteria for glaucoma.
    Ferreras A; Larrosa JM; Polo V; Pajarín AB; Mayoral F; Honrubia FM
    Acta Ophthalmol Scand; 2007 Feb; 85(1):73-9. PubMed ID: 17244214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of SITA and full-threshold standard perimetry to frequency-doubling technology perimetry in glaucoma.
    Boden C; Pascual J; Medeiros FA; Aihara M; Weinreb RN; Sample PA
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2433-9. PubMed ID: 15980232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity and specificity of the 76-suprathreshold visual field test to detect eyes with visual field defect by Humphrey threshold testing in a population-based setting: the Thessaloniki eye study.
    Topouzis F; Coleman AL; Yu F; Mavroudis L; Anastasopoulos E; Koskosas A; Pappas T; Dimitrakos S; Wilson MR
    Am J Ophthalmol; 2004 Mar; 137(3):420-5. PubMed ID: 15013863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. False-negative responses in glaucoma perimetry: indicators of patient performance or test reliability?
    Bengtsson B; Heijl A
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2201-4. PubMed ID: 10892863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [FDT versus automated standard perimetry in healthy subjects].
    Chiseliţa D; Ioana MC; Danielescu C; Mihaela NM
    Oftalmologia; 2006; 50(3):99-104. PubMed ID: 17144515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency-doubling perimetry: comparison with standard automated perimetry to detect glaucoma.
    Leeprechanon N; Giangiacomo A; Fontana H; Hoffman D; Caprioli J
    Am J Ophthalmol; 2007 Feb; 143(2):263-271. PubMed ID: 17178091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of efficient test procedures for frequency-doubling technology perimetry in normal and glaucomatous eyes.
    Turpin A; McKendrick AM; Johnson CA; Vingrys AJ
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):709-15. PubMed ID: 11867588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accuracy of combined GDx-VCC and matrix FDT in a glaucoma screening trial.
    Tóth M; Kóthy P; Vargha P; Holló G
    J Glaucoma; 2007 Aug; 16(5):462-70. PubMed ID: 17700289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The reliability of frequency-doubling technology (FDT) perimetry in a pediatric population.
    Becker K; Semes L
    Optometry; 2003 Mar; 74(3):173-9. PubMed ID: 12645850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corneal thickness measurements and frequency doubling technology perimetry abnormalities in ocular hypertensive eyes.
    Medeiros FA; Sample PA; Weinreb RN
    Ophthalmology; 2003 Oct; 110(10):1903-8. PubMed ID: 14522761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glaucoma detection with frequency doubling perimetry and short-wavelength perimetry.
    Horn FK; Brenning A; Jünemann AG; Lausen B
    J Glaucoma; 2007; 16(4):363-71. PubMed ID: 17570999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Test-retest variability of frequency-doubling perimetry and conventional perimetry in glaucoma patients and normal subjects.
    Chauhan BC; Johnson CA
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):648-56. PubMed ID: 10067968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Frequency doubling perimetry in terminal visual field defects].
    Muñoz-Negrete FJ; Rebolleda G; González Martín-Moro J; Cerio-Ramsden CD
    Arch Soc Esp Oftalmol; 2003 Apr; 78(4):203-9. PubMed ID: 12743844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glaucoma diagnostics.
    Geimer SA
    Acta Ophthalmol; 2013 Feb; 91 Thesis 1():1-32. PubMed ID: 23384049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic sensitivity of fast blue-yellow and standard automated perimetry in early glaucoma: a comparison between different test programs.
    Bengtsson B; Heijl A
    Ophthalmology; 2006 Jul; 113(7):1092-7. PubMed ID: 16815399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage.
    Prata TS; De Moraes CG; Teng CC; Tello C; Ritch R; Liebmann JM
    Ophthalmology; 2010 Jan; 117(1):24-9. PubMed ID: 19896197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency doubling perimetry and the detection of eye disease in the community.
    Cioffi GA; Mansberger S; Spry P; Johnson C; Van Buskirk EM
    Trans Am Ophthalmol Soc; 2000; 98():195-9; discussion 199-202. PubMed ID: 11190023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of community-based glaucoma screening using Frequency Doubling Technology and Heidelberg Retinal Tomography.
    Robin TA; Müller A; Rait J; Keeffe JE; Taylor HR; Mukesh BN
    Ophthalmic Epidemiol; 2005 Jun; 12(3):167-78. PubMed ID: 16036475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic capability of optical coherence tomography (Stratus OCT 3) in early glaucoma.
    Parikh RS; Parikh S; Sekhar GC; Kumar RS; Prabakaran S; Babu JG; Thomas R
    Ophthalmology; 2007 Dec; 114(12):2238-43. PubMed ID: 17561260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The results of screening frequency doubling technology perimetry in different locations of the community.
    Mansberger SL; Johnson CA; Cioffi GA
    J Glaucoma; 2007 Jan; 16(1):73-80. PubMed ID: 17224754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.